Literature DB >> 15598696

Reference values for insulin-like growth factor-binding protein-3 (IGFBP-3) and the ratio of insulin-like growth factor-I to IGFBP-3 throughout childhood and adolescence.

Chatarina Löfqvist1, Eva Andersson, Lars Gelander, Sten Rosberg, Lena Hulthen, Werner F Blum, Kerstin Albertsson Wikland.   

Abstract

To facilitate the diagnosis of GH deficiency and monitor GH therapy, we constructed two reference models to allow comparison of serum IGF binding protein (IGFBP)-3 concentrations and IGF-I to IGFBP-3 ratios among children throughout childhood and adolescence. This report presents equations for determining the sd score of IGFBP-3 and IGF-I to IGFBP-3 measurements for individual patients. The data set contains serum values from 468 healthy children and adolescents (232 males, 236 females; ages 1.1-18.3 yr) whose height, weight, and body mass index were within +/- 3 sd of means. Puberty was classified according to breast development (B) and testicular volume into pre-, early, mid-, and late puberty. The values of IGFBP-3 and IGF-I to IGFBP-3 ratios were log transformed, and multiple linear regression analysis was used to identify models for converting serum concentrations into sd scores. The models include the variables of age, gender, and puberty and take into account the interactions among these variables. The best linear models explain 42% of the variation in serum IGFBP-3 concentrations and 50% of the variation in serum IGF-I to IGFBP-3 concentrations. The relationship between age and log(IGFBP-3) was positive for boys in pre-, early, and midpuberty. In late puberty, values were higher than earlier in puberty, and there was a negative relationship with age. For girls the relationship between age and log(IGFBP-3) also was positive in pre- and early puberty, with larger effect for girls older than 8 yr. Values for girls in midpuberty were relatively constant, and in late puberty values were higher than earlier in puberty, and there was a negative relationship with age. The relationship between age and log(IGF-I to IGFBP-3 ratio) was positive for boys in pre-, early, and early midpuberty (volume = 9-14 ml). In late midpuberty (volume = 15-19 ml), the relationship between age and IGF-I to IGFBP-3 ratio was negative. In late puberty, values were relatively constant and higher than earlier in puberty. For girls in prepuberty, the relationship with age was positive, with a larger effect in girls older than 8 yr. In early puberty, the girls' values were relatively constant. In early midpuberty (B = 3), log(IGF-I to IGFBP-3 ratio) values were higher for girls than boys of the same age. In late midpuberty (B = 4), the relationship with age was negative, and in late puberty values were relatively constant and higher than earlier in puberty.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15598696     DOI: 10.1210/jc.2004-0812

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  21 in total

1.  Contributors to Pediatric Obesity in Adolescence: More than just Energy Imbalance.

Authors:  Michelle Cardel; Akilah Dulin-Keita; Krista Casazza
Journal:  Open Obes J       Date:  2011

2.  Determining the normal range for IGF-I, IGFBP-3, and ALS: new reference data based on current internal standards.

Authors:  Diana-Alexandra Ertl; Andreas Gleiss; Susanne Sagmeister; Gabriele Haeusler
Journal:  Wien Med Wochenschr       Date:  2014-09-04

3.  Temporal profiles of plasma proteome during childhood development.

Authors:  Chih-Wei Liu; Lisa Bramer; Bobbie-Jo Webb-Robertson; Kathleen Waugh; Marian J Rewers; Qibin Zhang
Journal:  J Proteomics       Date:  2016-11-23       Impact factor: 4.044

4.  Growth factors, adiponectin, leptin and body mass index in pre-pubertal children born large for gestational age.

Authors:  A S Challa; E N Evagelidou; V I Giapros; V I Cholevas; S K Andronikou
Journal:  J Endocrinol Invest       Date:  2010-06-28       Impact factor: 4.256

Review 5.  Advances in differential diagnosis and management of growth hormone deficiency in children.

Authors:  Camille Hage; Hoong-Wei Gan; Anastasia Ibba; Giuseppa Patti; Mehul Dattani; Sandro Loche; Mohamad Maghnie; Roberto Salvatori
Journal:  Nat Rev Endocrinol       Date:  2021-08-20       Impact factor: 43.330

6.  Catch-up growth in body mass index is associated neither with reduced insulin sensitivity nor with altered lipid profile in children born small for gestational age.

Authors:  P Torre; C Ladaki; G Scirè; G L Spadoni; S Cianfarani
Journal:  J Endocrinol Invest       Date:  2008-09       Impact factor: 4.256

7.  Seasonal variations in vitamin D in relation to growth in short prepubertal children before and during first year growth hormone treatment.

Authors:  B Andersson; D Swolin-Eide; B Kriström; L Gelander; P Magnusson; K Albertsson-Wikland
Journal:  J Endocrinol Invest       Date:  2015-08-09       Impact factor: 4.256

8.  Establishment of reference serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels of Tunisian children during childhood and adolescence.

Authors:  S Sfar; M Zaouali Ajina; S Ben Mdalla; A Baklouti; H Knani; Z Tabka; A Zbidi
Journal:  J Endocrinol Invest       Date:  2009-04-07       Impact factor: 4.256

9.  Growth hormone therapy does not alter the insulin-like growth factor-I/insulin-like growth factor binding protein-3 molar ratio in growth hormone-deficient children.

Authors:  G Scirè; C Del Bianco; G L Spadoni; S Cianfarani
Journal:  J Endocrinol Invest       Date:  2008-02       Impact factor: 4.256

10.  Proteins related to lipoprotein profile were identified using a pharmaco-proteomic approach as markers for growth response to growth hormone (GH) treatment in short prepubertal children.

Authors:  Björn Andersson; Gunnel Hellgren; Andreas F M Nierop; Ze'ev Hochberg; Kerstin Albertsson-Wikland
Journal:  Proteome Sci       Date:  2009-11-02       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.